EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …
poses several difficult clinical questions. These Clinical Practice Guidelines have been …
[HTML][HTML] Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors
AZ Fonseca, S Santin, LGL Gomes… - World journal of …, 2014 - ncbi.nlm.nih.gov
Radiofrequency ablation (RFA) has become an important option in the therapy of primary
and secondary hepatic tumors. Surgical resection is still the best treatment option, but only a …
and secondary hepatic tumors. Surgical resection is still the best treatment option, but only a …
Procedure‐related bleeding risk in patients with cirrhosis and severe thrombocytopenia
Background Gaps of knowledge still exist about the potential association between severe
thrombocytopenia and increased risk of procedure‐associated bleeding in patients with liver …
thrombocytopenia and increased risk of procedure‐associated bleeding in patients with liver …
Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study
Introduction The purpose of this study was to identify risk factors associated with local tumor
progression-free survival (LTPFS) and complications after colorectal liver metastases (CLM) …
progression-free survival (LTPFS) and complications after colorectal liver metastases (CLM) …
[HTML][HTML] Tips for preparing and practicing thermal ablation therapy of hepatocellular carcinoma
Y Minami, T Aoki, S Hagiwara, M Kudo - Cancers, 2023 - mdpi.com
Simple Summary Thermal ablation, including radiofrequency ablation (RFA) and microwave
ablation (MWA), for hepatocellular carcinomas (HCCs) is accepted as a curative treatment …
ablation (MWA), for hepatocellular carcinomas (HCCs) is accepted as a curative treatment …
[HTML][HTML] Complications after thermal ablation of hepatocellular carcinoma and liver metastases: imaging findings
F De Muzio, C Cutolo, F Dell'Aversana, F Grassi… - Diagnostics, 2022 - mdpi.com
Tumour ablation is a strategy of treatment of hepatic tumours in patients with small
hepatocellular carcinoma (HCC)(< 3 cm) or in patients unfit for surgical resection. Moreover …
hepatocellular carcinoma (HCC)(< 3 cm) or in patients unfit for surgical resection. Moreover …
Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience
H Takaki, K Yamakado, A Nakatsuka… - American Journal of …, 2013 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to retrospectively evaluate the frequency of and
risk factors for complications after liver radiofrequency ablation (RFA). MATERIALS AND …
risk factors for complications after liver radiofrequency ablation (RFA). MATERIALS AND …
中晚期肝癌临床治疗进展
李焱， 程朋 - 临床肝胆病杂志, 2014 - cqvip.com
肝癌的发病隐匿, 早期诊断困难, 进展较快, 临床上仅有不足30% 的患者就诊时可获得手术治疗
的机会, 因此非手术疗法是中晚期肝癌的主要治疗方式. 总结了几种主要的非手术治疗方式 …
的机会, 因此非手术疗法是中晚期肝癌的主要治疗方式. 总结了几种主要的非手术治疗方式 …
Hemostatic balance in patients with liver cirrhosis: report of a consensus conference
A Andriulli, A Tripodi, P Angeli, M Senzolo… - Digestive and Liver …, 2016 - Elsevier
Patients with cirrhosis present with hemostatic alterations secondary to reduced availability
of pro-coagulant and anti-coagulant factors. The net effect of these changes is a rebalanced …
of pro-coagulant and anti-coagulant factors. The net effect of these changes is a rebalanced …